Search results for "new-drug development"

Ligakem Bio Receives ADC Platform Technology Fees from Ono Pharmaceutical

Ligakem Bio Receives ADC Platform Technology Fees from Ono Pharmaceutical

Ligakem Bioscience announced on the 8th that it is set to receive milestone payments related to the development progress of the antibody-drug...
Next-Generation Precision Medicine for Cancer Treatment... Amgen Acquires UK Biotech for 1 Trillion Won

Next-Generation Precision Medicine for Cancer Treatment... Amgen Acquires UK Biotech for 1 Trillion Won

Global pharmaceutical company Amgen is acquiring a UK biotech for up to $840 million (approximately 1.21 trillion won) to introduce next-generation...
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial

Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial

Abl Bio announced on the 7th that it has confirmed positive anti-cancer efficacy in the dose expansion cohort of the...

"Diabetes Medication, Thought to Only Control Blood Sugar"... Can It Also Alter Cancer Growth?

Medications widely used as diabetes treatments have raised the possibility of influencing the occurrence and...
Celltrion Opens Production Facility in New Jersey Acquired from Eli Lilly

Celltrion Opens Production Facility in New Jersey Acquired from Eli Lilly

On the 5th , Celltrion announced on the 6th that it held an opening ceremony at its production facility located in...
Bukwang Pharmaceutical Selected as Final Acquirer of Korea Union Pharmaceutical... Production Capacity Increased by 30%

Bukwang Pharmaceutical Selected as Final Acquirer of Korea Union Pharmaceutical... Production Capacity Increased by 30%

Bukwang Pharmaceutical announced on the 5th that it has been selected as the final acquirer of Korea Union...

"Painkillers and Skin Decay on the Buttocks"... 51-Year-Old Man Suffers from 'This Syndrome', What Is It?

A rare case of extensive necrosis and ulceration of the skin at the injection site has been reported after the...
Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals

Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals

Ligand Pharmaceuticals announced on the 5th that it has recruited Dr. Han Jin-hwan, formerly of Merck, as the head of...
Samsung Bioepis to Directly Sell Ophthalmic Drug Baivubiz in Europe

Samsung Bioepis to Directly Sell Ophthalmic Drug Baivubiz in Europe

Samsung Bioepis announced on the 4th that it has recovered the European commercialization rights for the ophthalmic...
Personalized Cancer Vaccine That 'Remembers Cancer' Opens New Pathways

Personalized Cancer Vaccine That 'Remembers Cancer' Opens New Pathways

A domestic research team has developed artificial intelligence -based personalized cancer vaccine design technology...